HEALTH TECHNOLOGY

Amwell Honors Leading Healthcare Organizations for Telehealth Excellence and Advancing in Digital Care Delivery

Amwell | April 30, 2021

Amwell®, a national telehealth leader, named the winners of its annual Client Awards Program today. Organizations that showed a deep contribution to improving healthcare through empowering providers, developing new models of treatment, deploying innovative integrations, and closing care inequalities are honored with awards. Also during the pandemic, these organizations exemplified telehealth excellence and paved the way for new and innovative approaches to delivering and extending safe access to quality care.

“COVID-19 put a strain on the whole healthcare industry, but our clients have not only risen to the occasion, demonstrating unparalleled strength and resilience, but they have also pushed the boundaries of what is possible through telehealth and have used technology to reimagine care delivery models and innovate experiences to better serve their providers, members, and patients,” said Ido Schoenberg, MD, Chairman and co-CEO of Amwell. “We are incredibly grateful for the chance to help and empower so many of the world's leading healthcare agencies as they work to expand access to more affordable, high-quality care and improve outcomes for all.”

The winners were named at Amwell's annual Client Forum and were chosen from four categories, with preference given to organizations that made a meaningful difference through their telehealth activities.

Empowering Providers: For partnering with providers to enhance the virtual care experience for long-term adoption:

•    Hawai’i Medical Service Association (HMSA); and

•    Horizon Health Services

New Models, New Normal: For successfully adapting care delivery models to respond to rapidly changing healthcare circumstances:

•    Cook County Health; and
•    Northwell Health

Innovative Integrations: For identifying connection points within digital healthcare to improve clinical outcomes and user experiences:

•    AdventHealth; and
•    Anthem Inc.

Positive Impact: For proven success using telehealth to improve population needs and close inequities in care:

•    Blue Cross Blue Shield of Arizona;

•    M Health Fairview;

•    MedStar Health; and

•    National Association of Letter Carriers Health Benefit Plan

About Amwell

Amwell is a leading telehealth platform in the United States and around the world, connecting and empowering providers, insurers, patients, and innovators to provide more accessible, better quality care. Amwell claims that digital care delivery would have a transformative impact on healthcare. The company has a single, all-inclusive platform to serve all telehealth needs, including critical, acute, and post-acute care, as well as chronic care management and healthy living. Amwell has more than a decade of experience providing telehealth solutions for over 2,000 hospitals and over 55 health plan partners with over 36,000 employers, covering over 80 million lives.


 

Spotlight

As has been shown throughout history, the values of an individual, a group, an organization and even a country shape the progress of each entity. In health care settings, this effect is magnified by an order of magnitude given the intensity of the relationships that define the interactions. The stories of the individuals featured in this short video documentary that opened the 2014 Press Ganey National Client


Other News
HEALTH TECHNOLOGY

Softheon Expands to Artificial Intelligence in Care Management for Health Plans through Acquisition of NextHealth Technologies

Softheon | July 01, 2022

Softheon, a leading cloud-based eligibility, enrollment, and billing provider for health plans and government agencies, has acquired NextHealth Technologies, an AI-powered SaaS-based healthcare analytics platform. With the acquisition, Softheon will be better able to help health plans sell and deliver efficient, high-quality care through synergies in the companies' respective products and solutions. Health plans cans save tens or even hundreds of millions of dollars on medical and operational costs through Softheon's growing suite of solutions. The acquisition significantly enhances Softheon's talent density, enhancing go-to-market strategies, engineering processes, and leadership. The overall speed and capability of NextHealth's AI solutions will increase through Softheon's propriety technology. Softheon CEO, Eugene Sayan, will continue to lead the company. Eric Grossman, NextHealth's founder, has become the combined organization's Chief Commercial Officer, supporting Sayan's vision and the company's growth objectives. Sayan shared, "Artificial Intelligence in healthcare is here, and we are seeing the incredible impact it can have on both members and carriers. Our goal has been to make healthcare more affordable, accessible, and plentiful, and we see AI as a clear path forward to bring efficiencies to our carrier partners. This acquisition is a testament to Softheon's commitment to helping health plans tackle some of their biggest challenges, such as population health and the movement toward consumerism in healthcare." NextHealth Technologies, founded in 2013, offers a cloud-based platform that utilizes rigorous methodologies and standardized processes to enable health plan customers to identify impactable populations, measure which clinical initiatives work best for whom, and integrate data-driven decisions into the workflow in real-time to derive the highest ROI from their analytics investments. "We are thrilled to be part of Softheon's continued growth and expansion. This is an incredible opportunity for our respective teams. NextHealth's technical and service staff will continue to build and support cutting-edge applications of AI for carrier member populations with the support and resources of a larger company. We see a bright future for our health plan partners as we bring those tools to bear to deliver significant value and reduced costs." shared Grossman Softheon's purchase of NextHealth is expected to bring economies of scale and operating leverage to the combined company. NextHealth investors, Norwest Venture Partners and TT Capital Partners, will become investors in Softheon and expressed excitement on the prospects of the transaction. "Together, NextHealth and Softheon can provide better care at lower medical and administrative costs while advancing the application of AI in healthcare." said Casper de Clercq, General Partner at Norwest Venture Partners. "The acquisition of NextHealth will enhance Softheon's AI capabilities for health plans," said Ryan Engle, partner at TT Capital Partners, "Member data spanning shopping and enrollment through claims creates opportunities for proprietary methodologies to shape member behavior and create value for plans." Softheon has continued its growth and expansion, having completed more than 20 million enrollments since the inception of the Affordable Care Act, through public and private exchange technology. The acquisition comes after the company introduced its first foray into AI by creating a machine learning algorithm that predicts which members are at risk of letting their insurance coverage lapse, as featured in Bloomberg Law. About Softheon Founded in 2000, Softheon's Software-as-a-Service (SaaS) and Business Process-as-a-Service (BPaaS) solutions solve complex challenges for health plans and government health agencies. Currently, Softheon's solutions serve 8 State agencies and over 90 health plans. Issuers and consumers utilizing Medicaid, Medicare, and the ACA Marketplace benefit from Softheon's innovative technology that reduces administrative overhead and enhances user-experiences. Softheon is an Agent, Broker, and Merchant of Record that facilitates health insurance enrollment, administration, and renewal. About NextHealth Technologies NextHealth Technologies, based in Denver, is an AI-powered analytics platform that rapidly optimizes the effectiveness of health plans' cost, quality, and service enhancement initiatives resulting in significantly reduced costs and improved outcomes. Its cloud-based solution utilizes scientifically rigorous methodologies and standardized processes, enabling and promoting a culture of measurement. The platform is HITRUST-certified, scalable, and is deployed with expert services to ensure client adoption and success. Know what works™ and make it better.

Read More

HEALTH TECHNOLOGY

Essentia Health Selects Press Ganey as Patient Experience and Nursing Excellence Partner

pressganey | July 07, 2022

Press Ganey, renowned leader in patient, member, employee and consumer experience across the healthcare ecosystem announced it has entered into a multi-year agreement to provide technology, counsel and additional knowledge resources to Essentia Health, an integrated healthcare system serving patients in Minnesota, Wisconsin and North Dakota. Effective July 1, Press Ganey will support Essentia Health through rapid patient experience transformation and nursing excellence across the health system’s 14 hospitals, 72 clinics and 12 care facilities. “The best collaborations create something bigger than the sum of what each partner can create on their own, and I’m incredibly excited to see the great, industry-leading work that the Essentia Health and Press Ganey teams are going to do together,” said Lanie Dixon, Vice President of Patient Experience, Essentia Health. “Press Ganey’s unparalleled expertise in healthcare industry benchmarking, leading-edge technology and wealth of knowledge and resources will help us drive meaningful organizational change for our patients, physicians, and nurses, as Essentia continues its journey to Magnet Recognition® status.” Press Ganey partners with 98% of hospitals recognized by the American Nurses’ Association’s Magnet program, which recognizes excellence in nursing. Press Ganey will support Essentia Health through an integrated, multifaceted approach, including Dynamic Surveying: Customizable, digital surveys tailored to patients’ unique experiences. Narrative Dx: Artificial Intelligence (AI)-driven Natural Language Processing (NLP) to quickly and efficiently derive insights from patient feedback. National Database of Nursing Quality Indicators® (NDNQI®): Press Ganey’s proprietary national database of 250+ nursing measures and quality indicators to get unit-level analysis to help improve patient outcomes. Transparency: A technology platform that publishes authentic ratings and reviews from real patient experience surveys to provider profiles and directories, helping earn patient trust and driving appointment scheduling. Reputation Management: A cutting-edge, purpose-built for healthcare tool that captures patient sentiment and comments from reviews and social media sites into one consolidated dashboard to enable fast responses to online feedback. “We’re thrilled to partner with and support an industry leader in Essentia Health as they track their end-to-end patient journey and improve nursing excellence system-wide. Our integrated technology platform will provide the award-winning Essentia team with the ability to monitor the connections between patient and consumer experience and high-quality care, so they can continue to serve their communities in profound ways.” Dan Litwer, chief client officer, Press Ganey About Press Ganey Press Ganey invented the healthcare performance improvement movement over 35 years ago. Today it offers an integrated suite of solutions that address safety, clinical excellence, patient experience and workforce engagement. The company works with more than 41,000 healthcare facilities in its mission to reduce patient suffering and enhance caregiver resilience to improve the overall safety, quality and experience of care. About Essentia Health Essentia Health is an integrated health system serving patients in Minnesota, Wisconsin, and North Dakota. Headquartered in Duluth, Minnesota, Essentia Health combines the strengths and talents of 14,100 employees, including more than 2,100 physicians and advanced practitioners, who serve our patients and communities through the mission of being called to make a healthy difference in people’s lives. The organization lives out its mission by having a patient-centered focus at 14 hospitals, 72 clinics, six long-term care facilities, three assisted living facilities, three independent living facilities, six ambulance services, 20 retail pharmacies, and one research institute.

Read More

HEALTH TECHNOLOGY

Easterseals and the Abbott Fund Join Together to Advance Education and Health Equity

Easterseals | June 23, 2022

Easterseals announced today that it has received a grant of $750,000 from the Abbott Fund, the foundation of the global healthcare company Abbott, to pilot the Project on Education and Community Health Equity from now through 2025. The three-year project aims to address systemic barriers to high-quality education and healthcare experienced by children and families in underinvested communities. Research shows that many young children, particularly children with disabilities and children of color, face significant gaps in access to crucial health and social services that can provide the targeted support they need to be prepared to succeed in school. One example: according to a study by the American Academy of Pediatrics, Black children with autism and other disabilities are diagnosed an average of more than three years after their parents expressed concerns about their development. This delay in diagnosis means these children miss out on age-appropriate care and the chance to improve their health and cognitive skills, often resulting in them entering kindergarten with knowledge and skill deficits that many are not able to overcome throughout their K-12 educational journey. The Project on Education and Community Health Equity will create an integrated system that addresses the educational and healthcare needs of children to help them be kindergarten ready and reach their full potential. This includes work in three areas: expanding access to essential physical and mental health screenings and care for children; providing targeted social services to help families overcome gaps in basic needs, nutrition, transportation, and other social and economic barriers; and ensuring that early childhood administrators and educators have the right training to identify and address health and social challenges and provide culturally appropriate support for children. The project will be implemented at Easterseals Childhood Development Centers in Southern California, Atlanta and North Georgia, and the greater Washington, D.C., area. "Addressing the healthcare needs of infants and toddlers as early as possible in their lives is one of the critical ways in which Easterseals serves young children and families across the country. The Project on Education and Community Health Equity will allow us to better address healthcare disparities experienced by young BIPOC children and their families in historically underserved and marginalized communities, and to better understand the connection between more equitable access to healthcare and kindergarten readiness. Centering communities of color in our efforts is a critical strategy to close the gap. Outcomes from the project promise to inform its future expansion to early childhood and early education programs throughout the Easterseals Network of 70 affiliates in communities nationwide." Erika L. Watson, National Director of Childhood Development, Education and Equity at Easterseals "We're proud to support Easterseals' important work to help close equity gaps in education and community health," said Melissa Brotz, president of the Abbott Fund and vice president of Global Marketing and External Affairs at Abbott. "We're committed to advancing health equity and fighting racial health disparities, and our partnership with Easterseals will help reduce barriers to care for children, their families and their communities." The Project on Education and Community Health Equity builds on results seen through another Easterseals program, the Black Child Fund. Launched in 2021 with support from the Abbott Fund and others, the Black Child Fund advanced early identification and interventions among Black children with autism and other disabilities to reduce health disparities often experienced in early childhood. The Abbott Fund investment launched pilots at Easterseals locations serving Chicagoland and Greater Rockford, DuPage and the Fox Valley Region (IL), and Kansas City and St. Louis (MO). Through these pilot programs, an 87% increase in the number of Black families seeking services and support was realized, with more than 300 Black children screened for early diagnosis of autism and other disabilities in just one year. Of these children, 80% were five years old or younger, with 75% requiring and receiving additional services through Easterseals. An important outcome of these pilots has been the strengthening of relationships within Black communities across these Easterseals service areas to ensure more equitable and more culturally responsive services and supports to young children of color with disabilities and their families. The Centers for Medicare and Medicaid Services (CMS) released data revealing that during the pandemic public health emergency, rates for primary and preventive services among children in Medicaid and the Children's Health Insurance Program (CHIP) declined substantially. This decline in care for millions of children from low-income families will potentially have a significant impact on long-term health outcomes for the nearly 40 million children in the U.S. who rely on Medicaid and CHIP, including three-quarters of children living in poverty and many with special healthcare needs including infants, toddlers, and young children with disabilities. "Through the Project on Education and Community Health Equity, it is Easterseals' intention to address the disparities in healthcare among young children in low-investment communities and to understand the connection between health equity and early childhood educational attainment. We intend to center the experiences of children of color and their families, for whom inequities have only been exacerbated because of the pandemic," Watson concluded. The Abbott Fund's partnership with Easterseals supports Abbott's 2030 Sustainability Plan, which aims to advance health access and equity through partnership. Abbott's ongoing commitment to address health equity challenges includes targeted programs to increase diversity in clinical trials, create opportunities in STEM for women and underrepresented groups, and empower communities to break down social and economic barriers to better health. About Easterseals Easterseals is leading the way to full equity, inclusion, and access through life-changing disability and community services. For more than 100 years, we have worked tirelessly with our partners to enhance quality of life and expand local access to healthcare, education, and employment opportunities. And we won't rest until every one of us is valued, respected, and accepted. Through our national network of Affiliates, Easterseals provides essential services and on-the-ground supports to more than 1.5 million people each year – from early childhood programs for the critical first five years, to autism services, medical rehabilitation and employment programs, veterans' services, and more. Our public education, policy, and advocacy initiatives positively shape perceptions and address the urgent and evolving needs of the one in four Americans living with disabilities today. Together, we're empowering people with disabilities, families, and communities to be full and equal participants in society. About Abbott and the Abbott Fund Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 113,000 colleagues serve people in more than 160 countries.

Read More

MEDICAL DEVICES

Astorg Acquires Majority Interest in Avania

Avania | June 21, 2022

Avania, the preeminent, full-service global MedTech contract research organization announced that Astorg has acquired a majority stake in the company. Astorg, together with Kester Capital current investor who intends to retain a minority stake will actively support management’s plans to advance Avania’s development as a MedTech solution provider. Headquartered in the Netherlands, Avania was formed in March 2020 from the combination of five complementary businesses and started a successful journey to establish a fully integrated platform to serve sponsors worldwide in advancing medical technology products from early development to post-market ensuring customized, scalable solutions that optimize efficiencies and streamline the advancement of medical technology. Astorg brings an impressive global network of relationships in the MedTech space which will strengthen Avania’s pipeline and broaden its customer base while the capital access will help accelerate its growth, both organically and via acquisitions. “The platform we have built has positioned us ahead of our competition in the MedTech CRO space, and this deal will bring additional investment to strengthen our infrastructure, capital for acquisitions, and added support as we continue to grow Avania into the clear market leader. The largest CROs do not have the specialization that we bring, and the regional niche providers do not have the scale and reach of Avania. This unique positioning, along with the continued changes to the MedTech regulatory landscape, will allow us to push ourselves to the next era of growth.” Sapna Hornyak, president and CEO of Avania “We are extremely pleased to partner with Sapna and her team, as well as Kester, on this transaction,” said Managing Partner of Astorg Mid-Cap Edouard Pillot. “Being one of the global leaders in a profitable and fast-growing niche market, Avania squarely fits with Astorg’s investment criteria, and we are delighted to have Avania as our first Mid-Cap Healthcare deal, sitting within Astorg’s broader healthcare portfolio.” About Avania Avania is a leading, global full-service contract research organization focused on the management of clinical studies for medical technology, IVDs, biologics, and device-drug combination products internationally. Avania supports products from the first-in-human phase through the post-market phase with the same customized approach. When you need to advance your medical technology, it takes Avania. Avania’s vision is to be your trusted global partner in the evolution of your medical technology from innovation to commercialization to improving patient health and well-being. About Astorg Astorg is a leading private equity firm with over €17 billion of assets under management. We work with entrepreneurs and management teams to acquire market-leading global companies headquartered in Europe or the US, providing them with the strategic guidance, governance, and capital they need to achieve their growth goals. Astorg enjoys a distinct entrepreneurial culture, a long-term shareholder perspective, and a lean decision-making body. We have valuable industry expertise in healthcare, software, business-to-business professional services and technology-based industrial companies. Astorg has offices in London, Paris, New York, Frankfurt, Milan and Luxembourg. About Kester Capital Kester Capital is a primary buy-out specialist. Kester focuses on the healthcare, data & information and technology sectors, targeting businesses that require capital in order to unlock their potential.

Read More

Spotlight

As has been shown throughout history, the values of an individual, a group, an organization and even a country shape the progress of each entity. In health care settings, this effect is magnified by an order of magnitude given the intensity of the relationships that define the interactions. The stories of the individuals featured in this short video documentary that opened the 2014 Press Ganey National Client

Resources